EP0730865A1 — Use of serotonin and dopamine receptor blockers for the treatment of mental disorders associated with cerebrovascular disease
Assigned to Sumitomo Pharma Co Ltd · Expires 1996-09-11 · 30y expired
What this patent protects
The present invention provides an agent for treating mental disorders associated with cerebrovascular disorder. A compound which can block both serotonin-2 and dopamine-2 receptors is useful as a therapeutic agent therefor.
USPTO Abstract
The present invention provides an agent for treating mental disorders associated with cerebrovascular disorder. A compound which can block both serotonin-2 and dopamine-2 receptors is useful as a therapeutic agent therefor.
Drugs covered by this patent
- Risperdal (risperidone) · Johnson & Johnson (Janssen)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.